What Happens When Charcot-Marie-Tooth Disease Reaches the Voice: Recognizing Vocal Fold Paresis Before It Becomes an Emergency

Charcot-Marie-Tooth disease is usually discussed in terms of the hands and feet: the weakness, the muscle wasting, the years of orthopedic procedures that reshape a person's relationship with their own body. What gets discussed far less often, even among the physicians managing the condition, is that the same nerve degeneration responsible for those symptoms can eventually reach the voice box. A recent case series in The Laryngoscope examined four adults with CMT who developed vocal fold paresis, and the pattern that emerged is worth understanding, both for people living with CMT and for the physicians who treat them.

Charcot-Marie-Tooth Vocal Fold Paresis Is a Length-Dependent Problem

CMT is fundamentally a disease of long nerves. The peripheral nerves that travel the farthest from the spinal cord, the ones running down to the feet and hands, tend to show damage first and most severely, which is why the disease is so strongly associated with distal weakness. The nerve that controls the vocal folds, a branch of the vagus nerve, is also a long peripheral nerve, and the case series suggests it follows the same pattern of length-dependent decline. In all four patients reviewed, the left vocal fold, served by the longer of the two recurrent laryngeal nerves, was more severely affected than the right. That detail is not incidental. It is the same logic that governs symptoms in the feet before the hands, now showing up in an entirely different part of the body.

Why the Symptoms Are Easy to Miss

What stands out most in the case series is not the mechanism but the timeline. Every patient had lived with hoarseness, inspiratory noise, or exertional breathlessness for years, in one case more than a decade, before the connection to their airway was made. This is consistent with something clinicians who work with CMT have long observed: patients tend to be remarkably tolerant of gradual respiratory restriction, likely because the progression is so slow that no single day feels different from the one before it. Several patients in the series were only prompted to seek evaluation after a physician specifically pointed out the sound of their breathing. That detail matters, because it puts the responsibility for early recognition squarely on the clinical team surrounding a CMT patient, not on the patient's own sense that something has changed.

What This Means for Referral Pathways

For neurologists and other physicians managing CMT, the case series offers a fairly direct clinical takeaway: hoarseness, stridor, dyspnea on exertion, or sleep-disordered breathing in a CMT patient should prompt a laryngology and voice evaluation, even in the absence of an obvious respiratory complaint. Genetic testing, notably, was not a reliable predictor. The researchers identified vocal fold involvement in patients with mutations across several genes, including some, like MPZ, that had not previously been linked to laryngeal symptoms at all. In other words, a patient cannot be reassured out of monitoring based on which gene is involved. The absence of a known laryngeal-risk mutation does not mean the absence of laryngeal risk.

Why Voice and Swallow Therapy Belong in the Care Plan

None of this is to suggest that vocal fold paresis in CMT is common. It is not. But when it does occur, the case series is clear that it can progress to the point of requiring airway surgery, and that this progression can unfold over a span of months to years without dramatic warning signs. That timeline is exactly where a speech-language pathologist trained in voice and airway evaluation becomes clinically useful, not as a substitute for the ENT or neurologist managing the underlying disease, but as part of the surveillance loop that catches gradual change before it becomes a crisis. Regular voice and swallow evaluation gives a CMT patient a second set of eyes on symptoms they may have already adapted around without realizing it.

If you are living with Charcot-Marie-Tooth disease and have noticed changes in your voice, your breathing, or your swallowing, even changes that feel too gradual to mention, that pattern is worth bringing to a clinician who evaluates the larynx directly. And if you are a physician managing CMT patients, building a referral relationship with a voice-specialized SLP practice gives you a resource for exactly the kind of slow-moving symptom that is easy to overlook in a routine visit but difficult to reverse once it becomes severe.